Advanced Wound Care and Regenerative Medicine Access and Reform Act
Key claim: A newly introduced House bill would change federal rules to expand access to advanced wound-care and regenerative-medicine treatments and has been sent to the Energy and Commerce and Ways and Means committees for review.
Abstract
(HR6852 · 119th Congress) Latest action (2025-12-18): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why this matters
If enacted, the bill could broaden Medicare and other federal coverage pathways for advanced wound-care products and regenerative therapies, potentially affecting what patients with chronic or complex wounds pay and which treatments providers can offer. At introduction stage with dual committee referral, the practical impact remains contingent on committee markup and any coverage or payment provisions that survive.